AN2 Therapeutics, Inc. (ANTX)
3.61
+0.47
(+14.97%)
USD |
NASDAQ |
Apr 17, 16:00
3.62
+0.01
(+0.28%)
After-Hours: 20:00
AN2 Therapeutics Free Cash Flow : -29.83M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Relmada Therapeutics, Inc. | -45.79M |
| ACADIA Pharmaceuticals, Inc. | 6.308M |
| Alnylam Pharmaceuticals, Inc. | 465.38M |
| Savara, Inc. | -101.06M |
| BioMarin Pharmaceutical, Inc. | 717.02M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -5.236M |
| Cash from Investing (Quarterly) | 7.174M |
| Free Cash Flow Per Share (Quarterly) | -0.1725 |
| Free Cash Flow to Equity (Quarterly) | -5.236M |
| Free Cash Flow to Firm (Quarterly) | -5.236M |
| Free Cash Flow Yield | -27.35% |